Correlation Between Amplitech and Cyclo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amplitech and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amplitech and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amplitech Group and Cyclo Therapeutics, you can compare the effects of market volatilities on Amplitech and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amplitech with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amplitech and Cyclo Therapeutics.

Diversification Opportunities for Amplitech and Cyclo Therapeutics

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Amplitech and Cyclo is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Amplitech Group and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Amplitech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amplitech Group are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Amplitech i.e., Amplitech and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between Amplitech and Cyclo Therapeutics

Given the investment horizon of 90 days Amplitech is expected to generate 14.16 times less return on investment than Cyclo Therapeutics. But when comparing it to its historical volatility, Amplitech Group is 2.09 times less risky than Cyclo Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Cyclo Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  14.00  in Cyclo Therapeutics on August 27, 2024 and sell it today you would earn a total of  0.00  from holding Cyclo Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Amplitech Group  vs.  Cyclo Therapeutics

 Performance 
       Timeline  
Amplitech Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Amplitech Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Amplitech reported solid returns over the last few months and may actually be approaching a breakup point.
Cyclo Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical indicators, Cyclo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Amplitech and Cyclo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amplitech and Cyclo Therapeutics

The main advantage of trading using opposite Amplitech and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amplitech position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.
The idea behind Amplitech Group and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios